Dna Group (T.R.) Ltd (TLV:DNA)

Dna Group (T.R.) Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	68.31	66.7	65.73	23.69	0.04
Cash & Short-Term Investments	68.31	66.7	65.73	23.69	0.04
Cash Growth	2.42%	1.47%	177.46%	56304.76%	-88.74%
Other Receivables	-	-	-	-	0
Receivables	-	-	-	-	0
Prepaid Expenses	0.12	0.17	0.19	0.22	-
Other Current Assets	-	0.07	0.01	-	0.04
Total Current Assets	68.43	66.94	65.93	23.91	0.08
Long-Term Investments	35.85	13.72	16.06	30.7	18.41
Total Assets	104.28	80.66	81.99	54.62	18.49
Accounts Payable	0.48	0.08	0.09	-	-
Accrued Expenses	0.34	0.3	0.4	0.29	1
Short-Term Debt	-	-	-	-	0.28
Current Unearned Revenue	0.31	0.31	0.31	-	-
Other Current Liabilities	-	-	-	-	9.26
Total Current Liabilities	1.13	0.69	0.79	0.29	10.54
Long-Term Unearned Revenue	0.48	0.79	1.09	-	-
Long-Term Deferred Tax Liabilities	1.21	-	-	-	-
Total Liabilities	2.82	1.47	1.88	0.29	10.54
Common Stock	141.42	141.09	141.09	99.35	71.86
Retained Earnings	-51.44	-73.54	-72.36	-48.82	-67.2
Comprehensive Income & Other	11.49	11.63	11.38	3.8	3.29
Total Common Equity	101.47	79.19	80.11	54.33	7.95
Shareholders' Equity	101.47	79.19	80.11	54.33	7.95
Total Liabilities & Equity	104.28	80.66	81.99	54.62	18.49
Total Debt	-	-	-	-	0.28
Net Cash (Debt)	68.31	66.7	65.73	23.69	-0.24
Net Cash Growth	2.42%	1.47%	177.46%	-	-
Net Cash Per Share	0.55	0.54	0.56	0.27	-0.01
Filing Date Shares Outstanding	123.16	123.16	123.16	119.57	87.61
Total Common Shares Outstanding	123.16	123.16	123.16	99.7	30.83
Working Capital	67.3	66.26	65.14	23.63	-10.46
Book Value Per Share	0.82	0.64	0.65	0.54	0.26
Tangible Book Value	101.47	79.19	80.11	54.33	7.95
Tangible Book Value Per Share	0.82	0.64	0.65	0.54	0.26

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.